CoChat

Challenging Standard-of-Care Paradigms in the Precision Oncology Era

Open access
Subbiah, Vivek, Kurzrock, Razelle · 2018 · Trends in Cancer
Cited by 89

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The pace of genomic and immunologic breakthroughs in oncology is accelerating, making it likely that large randomized trials will increasingly become outdated before their completion. Traditional clinical research/practice paradigms must adapt to the reality unveiled by genomics, especially the need for customized drug combinations, rather than one-size-fits-all monotherapy. Precision oncology’s raison-d'être is to offer “the right drug for the right patient at the right time, ” a process enabled by transformative tissue and blood-based genomic technologies. Genomically-targeted therapies are most suitable in early disease, when molecular heterogeneity is less pronounced, while immunotherapy is most effective against tumors with unstable genomes. Next-generation cancer research/practice models will need to overcome the tyranny of tradition and emphasize an innovative, precise and personalized patient-centric approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trecan.2017.12.004

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 89

Metadata

Authors
Subbiah, V., & Kurzrock, R.
Venue
Trends in Cancer
Publisher
Elsevier BV
Published
2018-02
Volume
4
Issue
2
Pages
101-109
ISSN
  • 2405-8025 (ISSN-L)
  • 2405-8033
OpenAlex
W2784224482
Cited by
89
References
7
FWCI
0.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Challenging Standard-of-Care Paradigms in the Precision Oncology Era. https://app.cochat.ai/papers/10.1016/j.trecan.2017.12.004
The paper
Subbiah, V., & Kurzrock, R. (2018). Challenging Standard-of-Care Paradigms in the Precision Oncology Era. Trends in Cancer. https://doi.org/10.1016/j.trecan.2017.12.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.